HomeHYL • EBR
add
Hyloris Pharmaceuticals SA
Previous close
€11.85
Day range
€11.70 - €11.90
Year range
€10.60 - €14.10
Market cap
328.96M EUR
Avg Volume
15.30K
P/E ratio
-
Dividend yield
-
Primary exchange
EBR
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 827.00K | 80.17% |
Operating expense | 5.34M | 191.96% |
Net income | -4.56M | -33.68% |
Net profit margin | -551.87 | 25.80% |
Earnings per share | — | — |
EBITDA | -4.44M | -232.97% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 30.70M | -30.12% |
Total assets | 47.61M | -21.77% |
Total liabilities | 8.79M | 28.90% |
Total equity | 38.82M | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | -23.82% | — |
Return on capital | -27.95% | — |
Cash Flow
Net change in cash
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -4.56M | -33.68% |
Cash from operations | -4.30M | -40.98% |
Cash from investing | 4.87M | 187.29% |
Cash from financing | -54.00K | 98.45% |
Net change in cash | 518.00K | 104.28% |
Free cash flow | -2.96M | -207.87% |
About
Founded
2012
Website
Employees
42